|
| Press Releases |
|
 |
|
| Wednesday, March 25, 2026 |
|
|
Hengrui Pharma Announces Strong 2025 Annual Results |
| On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. more info >> |
|
|
營收淨利再創新高！恒瑞醫藥2025年營收316.29億元 同比增長13.02% 淨利77.11億元 同比增長21.69% |
| 3月25日，恒瑞醫藥發佈2025年年度報告。報告期內，公司堅持「科技創新+國際化」雙輪驅動戰略，實現業績持續增長，營收和淨利均再創新高。 more info >> |
|
| Wednesday, May 28, 2025 |
|
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully |
| The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. more info >> |
|
| Saturday, November 9, 2019 |
|
|
Novaliq and Jiangsu Hengrui Medicine Announce a Collaboration for Investigational NOV03 and CyclASol in China |
| Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiangsu Hengrui Medicine Co., Ltd. (SSE: 600276), a fully integrated biopharmaceutical company based in China, announced the closing of an exclusive license agreement to develop, manufacture and commercialize the innovative, water-free drugs NOV03 and CyclASol(R) for the treatment of dry eye disease in the People's Republic of China (mainland China, Hong Kong, Macau and Taiwan). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Genius Foundation's GENIUS Token Surges Following TGE, Briefly Tops $800 Million FDV
Apr 22, 2026 01:04: JST
|
|
|
Genius Foundation's GENIUS Token Surges Following TGE, Briefly Tops $800 Million FDV
Apr 21, 2026 22:46 HKT/SGT
|
|
|
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
Apr 21, 2026 20:52 JST
|
|
|
Seven HKTDC Lifestyle and Licensing mega events to open next week
Apr 21, 2026 19:51: JST
|
|
|
New Report Reveals Widespread Misunderstanding of Consumer Messaging App Security Across Government and Critical Infrastructure
Apr 21, 2026 19:00 HKT/SGT
|
|
|
Seven HKTDC Lifestyle and Licensing mega events to open next week
Apr 21, 2026 18:51 HKT/SGT
|
|
|
Hitachi to establish a new company with Nojima under a strategic partnership to accelerate growth of its home appliance business
Apr 21, 2026 19:21 JST
|
|
|
Global Turbine Asia Advances Aerospace Growth, Capabilities and Talent Development Through Strategic Partnerships
Apr 21, 2026 17:39 HKT/SGT
|
|
|
GMG's Graphene Engine Oil Additive G(R) LUBRICANT: Patent Granted in USA; Allowed in China
Apr 21, 2026 17:07 HKT/SGT
|
|
|
トヨタ、幹部職人事について
Apr 21, 2026 16:00: JST
|
|
|
Demanlink Unveils Sarawak's First Telecommunications Smart Pole in Siburan and Debuts its First Built-to-Suit Tower in Bintulu
Apr 21, 2026 16:00 HKT/SGT
|
|
|
CNN、「Global Perspectives」イベントシリーズをバンコクで開催
Apr 21, 2026 12:50: JST
|
|
|
Australia's data centre leaders to meet amid surge in AI-driven infrastructure investment
Apr 21, 2026 12:41 HKT/SGT
|
|
|
百望股份最新白皮書聚焦BEPS 2.0落地與數字化監管變局 破解跨境出海稅務合規痛點
Apr 21, 2026 12:04 HKT/SGT
|
|
|
百望股份最新白皮书聚焦BEPS 2.0落地与数字化监管变局 破解跨境出海税务合规痛点
Apr 21, 2026 11:41 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
